Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

How should healthcare harness creativity?

By Rob Gale

- PMLiVE

Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death

The antibody is the only long-acting combination shown to both prevent and treat COVID-19

- PMLiVE

Sandoz completes acquisition of GSK’s cephalosporin business

The acquisition confirms Sandoz’ commitment to antibiotics, following the announcement of further investment plans for European-based manufacturing network

- PMLiVE

Curb your conservatism: can pharma ditch its cautious approach to creativity in comms?

Chris Ross explores innovation in healthcare comms and finds creativity shouldn’t be comfortable

dengue fever mosquito

WHO has recommended GSK’s malaria vaccine for children

This is the first and only malaria vaccine to have been shown in pivotal long-term clinical trials to significantly reduce malaria in children

- PMLiVE

World Mental Health Day is on 10 October

You Okay, Doc? A call for more awareness and support for the mental health of doctors

The Real-Time Health System: Accelerating Workflows with Data

Bree Bush, Vice President, Chief Data Officer at GE Healthcare, dives into simulation modeling and advanced analytical tools to optimize inpatient, procedural, and clinic capacity; the concept of “real-time healthcare”;...

Impetus Digital

The Future of eHealth: Contactless Health Monitoring

Laurence Pearce, CEO & Founder of Xim Ltd, creators of Lifelight®, discusses the need for personal health monitoring; traditional issues associated with population health screening; AI, machine learning, and computer...

Impetus Digital

Two hands shaking symbolising partnership

Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly

In the first of this blog series, Patient Engagement Lead, Philippa Pristerà looks at making engagement processes more patient friendly

Cuttsy + Cuttsy

- PMLiVE

NICE recommends Novartis’ Adakveo for sickle cell disease

The treatment for sickle cell disease is the first in more than 20 years

- PMLiVE

Andy Black joins Lucid Group as non-executive chairman

Black is co-founder of Kinapse and a Professor of Practice at King’s College London

- PMLiVE

AstraZeneca requests Emergency Use Authorization from FDA for COVID-19 antibody

Phase 3 data shows the long-acting antibody combination produces a 77% reduction in the risk of developing symptomatic COVID-19

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links